Doença Relacionada à Igg4: Pancreatite Autoimune E Manifestações Extrapancreáticas by Fernandes DA et al.
Fernandes DA et al. / IgG4-related disease
Radiol Bras. 2016 Mar/Abr;49(2):122–125122
0100-3984 © Colégio Brasileiro de Radiologia e Diagnóstico por Imagem
Case Repo t
Immunoglobulin G4-related disease: autoimmune pancreatitis
and extrapancreatic manifestations*
Doença relacionada à IgG4: pancreatite autoimune e manifestações extrapancreáticas
Fernandes DA, Kido RYZ, Barros RHO, Martins DL, Penachim TJ, Caserta NMG. Immunoglobulin G4-related disease: autoimmune pancreatitis and
extrapancreatic manifestations. Radiol Bras. 2016 Mar/Abr;49(2):122–125.
Abstract
Resumo
We present a case of immunoglobulin G4 (IgG4)-related disease with pancreatic and extrapancreatic involvement, including the biliary
and renal systems. Given the importance of imaging methods for the diagnosis of IgG4-related disease and its differentiation from pancreatic
adenocarcinoma, we emphasize important abdominal computed tomography and magnetic resonance imaging findings related to this
recently recognized systemic autoimmune disease.
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Apresentamos um caso de doença relacionada à IgG4, com acometimento pancreático e extrapancreático biliar e renal. Dada a relevân-
cia dos métodos de imagem para seu diagnóstico e diferenciação com o adenocarcinoma pancreático, ressaltamos os principais achados
abdominais na tomografia computadorizada e ressonância magnética desta doença autoimune sistêmica recentemente reconhecida.
Unitermos: Pancreatite; Doenças autoimunes; Pâncreas; Tomografia computadorizada; Ressonância magnética.
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affects the pancreas, IgG4-related disease commonly presents
clinically as abdominal discomfort, obstructive jaundice, and
weight loss, the differential diagnosis with pancreatic adeno-
carcinoma being important(3,4).
The diagnosis of IgG4-related disease is based on clini-
cal, radiological, and pathological findings. Given the im-
portance of imaging methods for the diagnosis of IgG4-re-
lated disease, we report a case of IgG4-related disease, high-
lighting the main computed tomography (CT) and magnetic
resonance imaging (MRI) findings.
CASE REPORT
A 49-year-old male patient presented with pruritus, ab-
dominal discomfort, jaundice, choluria, hypocholic stools,
and weight loss (of 13 kg in five months). Physical exami-
nation revealed jaundice and no fever, as well as a soft abdo-
men that was painful on palpation of the right side. The
patient had a history of smoking and alcoholism. Labora-
tory tests showed elevated liver enzymes and bilirubin levels
(with an obstructive pattern), serum amylase and lipase lev-
els being within the normal range.
After an ultrasound showing bile duct dilatation, an en-
doscopic retrograde cholangiopancreatography revealed com-
mon bile duct stenosis. An endoscopic papillotomy was per-
formed, and a biliary stent was placed. Brush biopsy of the
bile duct was negative for neoplasia.
Abdominal CT and MRI scans showed diffuse pancreatic
enlargement with loss of the normal pancreatic lobulation
and roughness, a hypoenhancing peripancreatic halo in the
tail of the pancreas, and hypoenhancing renal nodules with
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INTRODUCTION
Immunoglobulin G4 (IgG4)-related disease is a systemic
autoimmune disease with pancreatic and extrapancreatic
abdominal manifestations; it can affect the bile ducts, kid-
neys, lymph nodes, prostate, and retroperitoneum, occurring
primarily in the 6th and 7th decades of life(1,2). Although
the full range of visceral involvement has yet to be fully de-
scribed, involvement of the salivary glands, periorbital tis-
sues, meninges, lungs, aorta, pericardium, breasts, thyroid,
and skin have been reported. Given that it most commonly
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partially ill-defined borders (Figures 1 and 2). Magnetic reso-
nance cholangiography showed bile duct dilatation (Figure 3).
Given the suspicion of IgG4-related disease, renal and
pancreatic biopsies were performed. Examination of the bi-
opsy samples showed dense, mixed lymphoplasmacytic in-
flammatory infiltrate with no evidence of epithelial neopla-
sia, most of the plasma cells in the infiltrate being IgG4-
positive. Taken together, the imaging and histopathologi-
cal findings confirmed the diagnosis of IgG4-related disease;
the patient was started on corticosteroid therapy, which re-
sulted in significant clinical and radiological improvement
after approximately 16 weeks (Figure 4). At this writing, the
patient is receiving outpatient follow-up care and respond-
ing well to treatment.
DISCUSSION
IgG4-related disease is a recently recognized disease that
was described as a specific clinical and pathological entity
in 2003(1). It is characterized by lesions showing fibrosis-
associated inflammatory response and lymphoplasmacytic
Figure 2. Axial abdominal MRI scan.
A: T1-weighted image without con-
trast. Diffusely increased, slightly
hypointense pancreas with loss of the
normal pancreatic roughness (solid
arrow). Note also a hypointense re-
nal nodule. B: Contrast-enhanced
T1-weighted image, portal phase.
Hypoenhancing peripancreatic halo
(solid arrow), together with hypo-
enhancing, partially ill-defined renal
nodules. C: T2-weighted image. Dif-
fusely increased pancreas, short-
ened pancreatic tail, and loss of the
normal pancreatic roughness (a “sau-
sage-like” pancreas), as well as dif-
fuse, irregular narrowing of the main
pancreatic duct (solid arrow), together
with hypoenhancing, partially ill-de-
fined renal nodules. D: Diffusion re-
striction in the entire pancreas, with
an ADC value of 0.839 × 10–3
mm2/s (solid arrow), as well as in the
renal nodules (dashed arrows).
Figure 1. Axial contrast-enhanced
CT scan of the abdomen, nephro-
graphic phase. A: diffuse pancreatic
enlargement (solid arrow). Note also
a biliary stent in the common bile
duct and hypoenhancing cortical nod-
ules in both kidneys (dashed arrows).
B: Retraction and obliteration of the
pancreatic tail, together with a
hypoenhancing halo (solid arrow), in
addition to the renal nodules.
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infiltration rich in tissue IgG4-positive plasma cells, consti-
tuting a spectrum of fibroproliferative diseases including
autoimmune pancreatitis, sclerosing cholangitis, sclerosing
sialadenitis, sclerosing mesenteritis, inflammatory pseudo-
tumor, and retroperitoneal fibrosis.
According to the international consensus diagnostic cri-
teria for autoimmune pancreatitis, there are two specific sub-
types of autoimmune pancreatitis (types 1 and 2), which can
be differentiated on the basis of five cardinal criteria: a) im-
aging changes in the pancreatic parenchyma and duct; b) se-
rology (for IgG4 and IgG antinuclear antibodies); c) extra-
pancreatic involvement; d) histology; e) response to corti-
costeroid therapy(5).
The diagnosis of type 1 and 2 autoimmune pancreatitis
can be definitive or probable, and, in many cases, the dis-
tinction between the two subtypes is impossible. Type 1
autoimmune pancreatitis is also known as lymphoplasmacytic
sclerosing pancreatitis and is the most common manifesta-
tion of IgG4-related disease, pancreatic involvement being
classified as diffuse, focal, or multifocal. In the case presented
here, a probable diagnosis of type 1 autoimmune pancreati-
tis was established. Diffuse pancreatic involvement is the most
common type of pancreatic involvement and includes dif-
fuse pancreatic enlargement with loss of the normal pancre-
atic lobulation and roughness (a “sausage-like” pancreas),
which is due to the lymphoplasmacytic infiltrate and oblit-
erative phlebitis associated with IgG4-related disease. On
MRI scans, the pancreas appears slightly hyperintense on T2-
weighted images and hypointense on T1-weighted images;
a thin, hypointense halo is sometimes seen on T1- and T2-
weighted images. In 16–80% of cases, there is delayed, mild
homogeneous enhancement after contrast administration, with
a thin, hypoenhancing peripancreatic halo, indicating inflam-
matory and fibrotic changes in peripancreatic tissues, as well
as irregular narrowing of the main pancreatic duct(2–4), all
of which were observed in the case presented here. In cases
of focal or multifocal involvement, there are relatively well-
defined lesions associated with ductal stenosis and upstream
dilatation(1).
Autoimmune pancreatitis can mimic pancreatic adeno-
carcinoma, especially when the disease is limited to the head
of the pancreas (as it is in approximately 80% of cases). The
two entities can be differentiated by determining the follow-
ing: whether or not the main duct penetrates the mass—it
does in cases of pancreatitis, but it does not in cases of neo-
plasia(2–4); the intensity of contrast enhancement, which is
lower in cases of adenocarcinoma than in cases of pancreati-
tis(3); and apparent diffusion coefficient (ADC) values, which
are lower in cases of pancreatitis than in cases of adenocar-
cinoma, a cut-off ADC value of 1.075 × 10–3 mm2/s having
been suggested for differentiating between the two entities(6).
Cases of diffuse pancreatic involvement should be differen-
tiated, first and foremost, from acute pancreatitis; in cases
of IgG4-related disease, there is a peripancreatic halo, little
or no peripancreatic densification, and no fat necrosis. In
most cases, however, a combination of clinical, laboratory,
imaging, and histological criteria is required for such dif-
ferentiation(2–4).
With regard to extrapancreatic manifestations, the biliary
tree is the most common site of involvement; bile duct wall
thickening, stenosis, irregularity, and upstream dilatation can
occur, the intrapancreatic portion being the most commonly
affected site(1–4). These findings are similar to those in pa-
tients with primary sclerosing cholangitis (PSC), the differ-
ential diagnosis between the two entities posing a challenge.
Patients with PSC are generally less symptomatic, whereas
those with IgG4-related sclerosing cholangitis have disease
that is more acute and of a shorter duration. Patients with
PSC have multifocal involvement of short segments includ-
ing intrahepatic or extrahepatic bile ducts—normal segments
alternating with slightly dilated segments to produce a
“beaded” appearance—whereas patients with IgG4-related
sclerosing cholangitis have strictures that typically affect a long
segment and are continuous with prestenotic dilatation(2–4).
Figure 3. Magnetic resonance cholangiography
showing bile duct dilatation up to the intrapan-
creatic common bile duct (arrow).
Figure 4. Axial abdominal MRI scan taken after corticosteroid therapy. A: Contrast-enhanced T1-weighted image,
portal phase. Normally sized pancreas without the peripancreatic halo seen before (solid arrow). No renal nodules
were seen on T1-weighted images. B: T2-weighted image. Normal-sized pancreas without the main pancreatic
duct changes seen previously (solid arrow). Small nodules remain, seen only on T2-weighted images (dashed
arrows) and smaller in size than those observed before corticosteroid therapy.
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Given this challenge, the American Association for the Study
of Liver Diseases recommends that serum IgG4 levels be
measured in all patients with possible PSC in order to ex-
clude IgG4-related sclerosing cholangitis(7).
Renal involvement occurs in up to one third of patients
and is usually multiple and bilateral, presenting as round or
wedge-shaped cortical nodules, small peripheral cortical le-
sions, renal masses (pseudotumors), or renal pelvic involve-
ment. Contrast-enhanced CT typically shows hypodense lesions
showing mild contrast enhancement in later phases. On MRI
scans, the lesions are isointense/hypointense on T1-weighted
sequences and hypointense on T2-weighted sequences(2,8).
These imaging findings reflect histopathological features
including lymphoplasmacytic infiltration of the renal inter-
stitium, with an increased number of IgG4-positive plasma
cells, and fibrosis(2,8). The combined presence of pancreatic
and extrapancreatic manifestations further supports the di-
agnosis of IgG4-related disease, as in the present case.
After clinical improvement with corticosteroid therapy,
patients with IgG4-related disease require follow-up, given
that there have been reports of an increased relative risk of
cancer in the year following diagnosis—including stomach
cancer (the most common type of cancer in such patients),
lung cancer, prostate cancer, colon cancer, non-Hodgkin lym-
phoma, bile duct cancer, and thyroid cancer(9). Although the
number of studies on this topic is growing, the natural his-
tory and long-term prognosis of IgG4-related disease have
yet to be well defined. Therefore, patient monitoring and a
multisystem evaluation approach, including periodic imag-
ing, are required.
Given that IgG4-related disease can mimic neoplastic
lesions, there is a risk that a more aggressive approach might
be taken if a diagnosis of IgG4-related disease is not taken
into account. The case reported here shows that radiologists
should be aware of this possibility in order to establish the
correct diagnosis and select the most appropriate therapy.
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